UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Oak Ridge Investments LLC

Oak Ridge Investments LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 41,946 shares of the healthcare conglomerate’s stock after buying an additional 2,227 shares during the quarter. UnitedHealth Group makes up 1.7% of Oak Ridge Investments LLC’s portfolio, making the stock its 11th largest holding. Oak Ridge Investments LLC’s holdings in UnitedHealth Group were worth $21,219,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Pacer Advisors Inc. grew its holdings in UnitedHealth Group by 5.7% in the second quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock valued at $33,540,000 after purchasing an additional 3,525 shares during the period. Garden State Investment Advisory Services LLC grew its stake in UnitedHealth Group by 13.5% in the 2nd quarter. Garden State Investment Advisory Services LLC now owns 1,049 shares of the healthcare conglomerate’s stock valued at $536,000 after acquiring an additional 125 shares during the period. Columbus Hill Capital Management L.P. acquired a new position in UnitedHealth Group during the second quarter worth $14,789,000. Summit Trail Advisors LLC grew its position in shares of UnitedHealth Group by 33.3% in the second quarter. Summit Trail Advisors LLC now owns 12,008 shares of the healthcare conglomerate’s stock valued at $6,115,000 after purchasing an additional 2,999 shares during the period. Finally, Transatlantique Private Wealth LLC lifted its stake in UnitedHealth Group by 9.9% in the 2nd quarter. Transatlantique Private Wealth LLC now owns 2,594 shares of the healthcare conglomerate’s stock valued at $1,291,000 after buying an additional 234 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research analyst reports. UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Stephens raised their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Two analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Stock Down 0.1 %

Shares of UNH opened at $510.03 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a market capitalization of $469.37 billion, a PE ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62. The company’s 50-day simple moving average is $549.37 and its 200-day simple moving average is $562.73. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 earnings per share. The company’s revenue was up 6.8% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.